Daptomycin — Drug Intelligence | 13 EU Trials

Filter these 13 trials by condition, phase, country and more.

Open in Search →

13 Registered trials

7 Recruiting

1 Completed trials

8 Sponsors

6 Countries

Phase III

Phase IV

Phase III: 4 Phase II: 1 Phase III/IV: 1 Phase IV: 7

Indications tested

Antibiotic level therapeutic 1 Endocarditis enterococcal 1 Bacterial infection 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 3 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 3 Assistance Publique Hopitaux De Paris 2 Friedrich-Schiller-Universitaet Jena 1 Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau 1 Hvidovre Hospital 1 Region Skane 1 University Medical Center Utrecht 1

All trials

13 total

Clinical impact of pharmacokinetic monitoring of antibiotics in critically ill patients Pending

2023-504480-17-00 Phase IV 1 country Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
Osteoarticular infections on prosthesis: impact of three antibiotic therapies on the digestive microbiota Pending

2024-513298-29-00 Phase II 1 country Centre Hospitalier Universitaire De Nice
Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
Optimal Duration of Antibiotic Therapy in Drained Pyogenic Liver Abscess: 3 weeks versus 6 weeks, a non-inferiority trial Pending

2025-520940-14-00 Phase IV 1 country Assistance Publique Hopitaux De Paris
Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci Pending

2026-526149-91-00 Phase III 1 country Friedrich-Schiller-Universitaet Jena
Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter ran… Recruiting

2024-518018-22-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting

2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting

2024-511719-40-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting

2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Accelerated treatment of infectious endocarditis Recruiting

2023-507652-76-00 Phase III/IV 1 country Region Skane
Clinical trial to evaluate the safety and efficacy of a 7-day versus 14-day treatment for enterococcal infections. Ended

2023-508456-18-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…

Showing 1–13 of 13 trials

← All drugs A–Z